People · Operator
Named in public records as an officer, director or promoter · active 2023–2023 · Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| NuvOx Therapeutics, Inc. | — | Pharmaceuticals | Seed | $1.3M | $1.0M | 2023 |
Richard C Carmona at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Richard C Carmona on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Jon Saxe | 1 | 4 |
| Jennifer Johnson | 1 | 3 |
| Richard T. Carmona | 1 | 1 |
| Jonathan T. Schilling | 1 | 1 |
| Rong Wang | 1 | 1 |
| Evan Unger | 1 | 1 |
| Marvin J. Slepian | 1 | 1 |
| Jon C Saxe | 1 | 1 |
| Marvin C Slepian | 1 | 1 |
| Rong C Wang | 1 | 1 |
| Evan C Unger | 1 | 1 |
| Jonathan C Schilling | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.